Eureka Alert

LUGANO, 28 August 2018 – Gender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field’s growing interest in precision medicine and accumulating evidence that sex is a major factor in disease risk and response to treatment. At the ESMO workshop, “Gender medicine meets oncology”, to be held in Lausanne, Switzerland, on 30 November and 1 December 2018, (1) a multidisciplinary faculty of experts will discuss the concepts and methods of gender medicine and their implications for clinical practice and research in oncology.

According to Dr. Anna Dorothea Wagner from Lausanne University Hospital, who initiated the workshop and co-authored a recent paper (2) on the subject, “the need for further research to understand gender impacts in oncology is significant. “This exceptional meeting format, which will bring together pharmacologists, statisticians, basic scientists and medical oncologists from different specialties, will in fact be the first organised discussion of gender medicine in the oncology community.

“With efforts to include sex aspects in biomedical research abounding in other areas, like cardiovascular medicine, it was high time for us in the oncology field to take notice. Now, ESMO is providing the ideal setting to do just that” said


Article originally posted at

Click here for the full story


Privacy Policy / Terms Of Use

       Powered by MMD